| Bio-Link News |
|
16/04/2019 – Bio-Link will be represented at both The Bridge Program and The BridgeTech Program this year…more. 1/03/2019 – Pathway to a Technology Licensing Deal – Christopher Boyer’s Presentation to MHx & The Royal Melbourne Hospital is now available. 20/02/2019 – Bio-Link’s Dr Christos Papadimitriou is one of the lead authors of a newly published study. |
| Client News |
|
2/14/2019 – Actinogen Medical dose first patient in the XanaHES clinical trial of Xanamem in healthy volunteers…more. 25/05/2018 – Actinogen Medical announce a positive DSMB interim analysis of ph II Alzheimer’s trial and a major $15M placement…more 01/05/2018 – Congratulations to our client, CMRI, for receiving an additional $41 million for the ProCan project…see post. |
| Industry News |
| Welcome to Bio-Link |
|
Bio-Link is a strategic consulting and biotechnology business development company that works with Australian and international life sciences companies and academic institutions to facilitate deals based on strategic technology analysis and consulting, business development, project management and deal negotiation. Bio-Link also provides technology scouting and representation services for Australian and international companies. Bio-Link has offices in Melbourne and Sydney. Please explore our website to learn more about Bio-Link’s services and client endorsements and our portfolio of client technologies. Follow @BioLinkAus |
Bio-Link employs BDcrowd™ and Medtrack Pharma Intelligence software to execute on business development
|
Bio-Link is a proud member of
|
